5 ms·
UT Health develops drug that doubles survival for glioblastoma patients
- hentrep 2y agoLink to primary manuscript: https://www.nature.com/articles/s41467-025-57263-1 https://www.nature.com/articles/s41467-025-57263-1 Caveat: Single-arm Phase 1 trial of just 21 patients. Graphical abstract in the supplementary materials: https://static-content.springer.com/esm/art%3A10.1038%2Fs41467-025-57263-1/MediaObjects/41467_2025_57263_MOESM1_ESM.pdf https://static-content.springer.com/esm/art%3A10.1038%2Fs414...